<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02446314</url>
  </required_header>
  <id_info>
    <org_study_id>RDG-001</org_study_id>
    <nct_id>NCT02446314</nct_id>
  </id_info>
  <brief_title>An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Naurex, Inc, an affiliate of Allergan plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a 6 month dietary intervention with wild
      blueberry powder and extract stabilised with L-cysteine and L-glutathione have an effect on
      cognitive performance in participants aged between 65 - 80.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventions: A placebo and two different wild blueberry products will be used in this study
      (see Table 1). A wild blueberry powder at two different doses and a single wild blueberry
      extract. The wild blueberry powder will be used at a 450 mg-dose, to which 45 mg of
      L-Cysteine and 5 mg of L-Glutathione will be added (wild blueberry powder-450), as well as at
      a 900 mg-dose, to which 90 mg of L-Cysteine and 10 mg of L-Glutathione will also be added
      (wild blueberry powder-900). The wild blueberry extract will consist of 100 mg of wild
      blueberry extract supplemented with 10 mg of L-Cysteine and 1 mg of L-Glutathione.
      Participants will be asked to consume two capsules daily with their normal breakfast. The
      capsules will be packed in blister packs with 4 capsules per blister. Each box contains 4
      blisters (or a total of 16 capsules) in order to provide for 1 week of study medication, with
      2 capsules remaining. Participants will be instructed to return the left-over investigational
      product weekly (i.e two capsules) using stamped addressed envelopes supplied by the
      experimenters. Weekly assessment of left-over investigational product will allow for
      continued compliance verification.

      Procedure: The study comprises of a telephone screen and then six visits, including a
      familiarization visit (week T-1), three test visits (week 0, 12 and 24), and two control
      visits (week 6 and 18). Participants may stop the study treatment without stating any reason
      at any time during the study. In addition, a participant will be withdrawn from the study if:
      a subject requests discontinuation, he/she exhibits a serious adverse event to any component
      of the test product, the participant significantly violates the inclusion or exclusion
      criteria, an intercurrent illness emerges and/or the investigator's opinion is that
      withdrawal is appropriate and in the best interest of the participant. If a participant
      withdraws from the study, he/she will be encouraged to make a final visit as soon as
      possible, irrespective of the reason for withdrawal, to complete a final battery of cognitive
      tasks.

        1. Screening: once a participant has indicated that they wish to join the trial they will
           be contacted by telephone for a brief screening session. The research associate (RA)
           will give a brief overview of the study and will ascertain that each interested
           volunteer is willing to participate for the entire duration of the study and to check
           that they fulfill our inclusion/exclusion criteria. Once confirmation of suitability for
           the study is confirmed, the RA will schedule their familiarization visit.

        2. Familiarization Visit: Volunteers will be asked to attend the Nutritional Psychology
           Unit at the University of Reading where they will receive a detailed explanation on the
           study by the participating research associate and will be asked to sign the informed
           consent form before any study procedure starts. A log will be kept identifying all
           participants having signed the informed consent form (ICF) and the participant will be
           allocated a participant number. Once consent has been given, the inclusion/exclusion
           criteria will be checked once again and vital signs (blood pressure and heart rate) and
           anthropometric measurements (height, weight, BMI) will be taken. The participants will
           then be asked to complete a number of questionnaires and cognitive tasks comprising: (i)
           Yale Physical Activity Questionnaire; (ii) Frequency of Forgetting Questionnaire to give
           a baseline assessment of their memory performance; and (iii) Computerized Global
           Cognitive Health Assessments (NART, CERAD, MMSE, letter and category fluency; unless as
           a member of the Older Adult Panel these data have been collected from them in the
           preceding 3 months). Finally, participants will be given training on the cognitive test
           battery (tasks outlined below) that will be used during the study to reduce the chances
           of 'practice' adversely effecting performance on subsequent test days. Before leaving
           the laboratory, participants will be asked to keep a 72 hour food diary (consisting of 2
           week days &amp; 1 weekend day) so that background flavonoid intakes can be measured prior to
           the start of the intervention.

        3. Test Visits (Weeks 0, 12 and 24): All of these sessions will be held in the morning
           (typically 8am-10am arrival time to suit participants individual needs). Participants
           will attend the laboratory in a fasted state and on arrival at the laboratory we will
           check participants still fulfill our inclusion/exclusion criteria, their general
           well-being, notification of any adverse events, any issues with compliance, and to check
           whether there have been changes to any concomitant medication. Blood pressure and heart
           rate will also be measured, and the food diary will be collected (week 0 and 24 only).
           They will then receive a standard low-flavonoid breakfast and will complete the battery
           of cognitive tasks (see below). Subjects will then be given their intervention
           (sufficient quantity until their next test session, in blister packs, weeks 0 and 12
           only), and will then be requested to consume 2 capsules each day. At week 24 only, the
           Yale Physical Activity and Frequency of Forgetting questionnaires will also be
           administered, and weight will be measured.

        4. Control Visits (weeks 6 &amp; 18): These sessions can take place at any time of day to suit
           the participant. Participants will attend the laboratory at the University of Reading to
           collect the next 6 week supply of their intervention. During these visits we will check
           that participants still fulfill our inclusion/exclusion criteria, informally check their
           well-being, inquire whether there have been any adverse events, and confirm that there
           have not been any changes to their concomitant medication. At week 18 only participants
           will be given another copy of the 72 hour food diary (consisting of 2 week days &amp; 1
           weekend day and asked to complete this before they return for their test visit in week
           24.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Words Correctly Recognised.</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>Participants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Number of Correct Sequences Recalled</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>Participants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>12, and 24 weeks.</time_frame>
    <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>12, and 24 weeks.</time_frame>
    <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive Affect Score</measure>
    <time_frame>12, and 24 weeks</time_frame>
    <description>As measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative Affect Score</measure>
    <time_frame>12, and 24 weeks.</time_frame>
    <description>As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Cognitive Decline</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wild Blueberry Powder - 450mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wild Blueberry Powder - 900 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wild Blueberry extract 100mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wild Blueberry Powder - 450mg</intervention_name>
    <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
    <arm_group_label>Wild Blueberry Powder - 450mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wild Blueberry Powder - 900 mg</intervention_name>
    <description>Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
    <arm_group_label>Wild Blueberry Powder - 900 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wild Blueberry extract 100mg</intervention_name>
    <description>Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
    <arm_group_label>Wild Blueberry extract 100mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overall healthy volunteers as proven by medical history and/or physical examination
             and of all ethnicity and socioeconomic status

          -  Free-living

          -  Subjects with subjective memory complaints

          -  MMSE: 24-30

          -  Subjects are willing to maintain their normal eating habits and exercise habits to
             avoid changes in body weight over the duration of the study

          -  Being willing to complete the food diaries and questionnaires

          -  Able to give signed written informed consent

          -  Signed informed consent form

        Exclusion Criteria:

          -  Use of complementary and alternative medicine

          -  History of metabolic disorder, diabetes, substance abuse

          -  Subjects diagnosed with psychiatric or neurological conditions

          -  Subjects using medications that might affect the outcome measures (such as
             antidepressant and sleeping medication), or planned changes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire M Williams, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reaiding</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emilie Fromentin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>NATURIEX-DBS,, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Reading</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 6AH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>How, P.S., Ellis, J.A., Neshatdoust, S., Spencer, J.P.E. (2008). The impact of plant-derived flavonoids on mood, memory and motor skills in healthy older UK adults. Proceedings of the Nutrition Society, 67, E316.</citation>
  </reference>
  <reference>
    <citation>Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010 Apr 14;58(7):3996-4000. doi: 10.1021/jf9029332.</citation>
    <PMID>20047325</PMID>
  </reference>
  <reference>
    <citation>Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr. 2009 Dec;4(4):227-42. doi: 10.1007/s12263-009-0135-4. Epub 2009 Aug 13.</citation>
    <PMID>19680703</PMID>
  </reference>
  <reference>
    <citation>Rendeiro C, Vauzour D, Kean RJ, Butler LT, Rattray M, Spencer JP, Williams CM. Blueberry supplementation induces spatial memory improvements and region-specific regulation of hippocampal BDNF mRNA expression in young rats. Psychopharmacology (Berl). 2012 Oct;223(3):319-30. doi: 10.1007/s00213-012-2719-8. Epub 2012 May 9.</citation>
    <PMID>22569815</PMID>
  </reference>
  <reference>
    <citation>Rendeiro C, Vauzour D, Rattray M, Waffo-Téguo P, Mérillon JM, Butler LT, Williams CM, Spencer JP. Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One. 2013 May 28;8(5):e63535. doi: 10.1371/journal.pone.0063535. Print 2013.</citation>
    <PMID>23723987</PMID>
  </reference>
  <results_reference>
    <citation>Whyte AR, Cheng N, Fromentin E, Williams CM. A Randomized, Double-Blinded, Placebo-Controlled Study to Compare the Safety and Efficacy of Low Dose Enhanced Wild Blueberry Powder and Wild Blueberry Extract (ThinkBlue™) in Maintenance of Episodic and Working Memory in Older Adults. Nutrients. 2018 May 23;10(6). pii: E660. doi: 10.3390/nu10060660.</citation>
    <PMID>29882843</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>May 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2015</study_first_posted>
  <results_first_submitted>October 10, 2018</results_first_submitted>
  <results_first_submitted_qc>June 24, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 8, 2019</results_first_posted>
  <last_update_submitted>June 24, 2019</last_update_submitted>
  <last_update_submitted_qc>June 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>Prof Claire Williams</investigator_full_name>
    <investigator_title>Associate Professor in Behavioural Neuroscience</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="P2">
          <title>Wild Blueberry Powder - 450mg</title>
          <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="P3">
          <title>Wild Blueberry Powder - 900 mg</title>
          <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="P4">
          <title>Wild Blueberry Extract 100mg</title>
          <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Zero to Twelve Weeks.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Thirteen to Twenty Four Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="B2">
          <title>Wild Blueberry Powder - 450mg</title>
          <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="B3">
          <title>Wild Blueberry Powder - 900 mg</title>
          <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="B4">
          <title>Wild Blueberry Extract 100mg</title>
          <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="31"/>
            <count group_id="B4" value="31"/>
            <count group_id="B5" value="122"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.8" spread="3.07"/>
                    <measurement group_id="B2" value="70.5" spread="2.87"/>
                    <measurement group_id="B3" value="70.3" spread="3.59"/>
                    <measurement group_id="B4" value="70.2" spread="4.30"/>
                    <measurement group_id="B5" value="70.5" spread="3.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="31"/>
                    <measurement group_id="B5" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Words Correctly Recognised.</title>
        <description>Participants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Words Correctly Recognised.</title>
          <description>Participants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.</description>
          <units>proportion of words correctly recognised</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" spread="0.02"/>
                    <measurement group_id="O2" value="0.85" spread="0.02"/>
                    <measurement group_id="O3" value="0.79" spread="0.02"/>
                    <measurement group_id="O4" value="0.90" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="0.02"/>
                    <measurement group_id="O2" value="0.88" spread="0.02"/>
                    <measurement group_id="O3" value="0.87" spread="0.02"/>
                    <measurement group_id="O4" value="0.88" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Number of Correct Sequences Recalled</title>
        <description>Participants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Correct Sequences Recalled</title>
          <description>Participants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.</description>
          <units>Correct number of sequences</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.15" spread="0.41"/>
                    <measurement group_id="O2" value="14.27" spread="0.40"/>
                    <measurement group_id="O3" value="15.42" spread="0.39"/>
                    <measurement group_id="O4" value="16.19" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.56" spread="0.48"/>
                    <measurement group_id="O2" value="16.348" spread="0.47"/>
                    <measurement group_id="O3" value="15.921" spread="0.46"/>
                    <measurement group_id="O4" value="16.302" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.</title>
        <description>Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.</title>
          <description>Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.11"/>
                    <measurement group_id="O2" value="0.08" spread="0.11"/>
                    <measurement group_id="O3" value="0.02" spread="0.11"/>
                    <measurement group_id="O4" value="0.28" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.09"/>
                    <measurement group_id="O2" value="0.13" spread="0.09"/>
                    <measurement group_id="O3" value="0.33" spread="0.08"/>
                    <measurement group_id="O4" value="0.2" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.</title>
        <description>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.</title>
          <description>Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.003" spread="0.067"/>
                    <measurement group_id="O2" value="0.009" spread="0.068"/>
                    <measurement group_id="O3" value="-0.137" spread="0.064"/>
                    <measurement group_id="O4" value="-0.037" spread="0.067"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.101" spread="0.065"/>
                    <measurement group_id="O2" value="-0.176" spread="0.066"/>
                    <measurement group_id="O3" value="-0.129" spread="0.062"/>
                    <measurement group_id="O4" value="-0.075" spread="0.065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line</title>
        <description>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line</title>
          <description>Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.09"/>
                    <measurement group_id="O2" value="-0.03" spread="0.08"/>
                    <measurement group_id="O3" value="-0.13" spread="0.08"/>
                    <measurement group_id="O4" value="0.03" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.07"/>
                    <measurement group_id="O2" value="-0.01" spread="0.07"/>
                    <measurement group_id="O3" value="-0.04" spread="0.07"/>
                    <measurement group_id="O4" value="0.02" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure</title>
        <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
        <time_frame>12, and 24 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.11" spread="2.09"/>
                    <measurement group_id="O2" value="124.51" spread="2.05"/>
                    <measurement group_id="O3" value="125.16" spread="2.03"/>
                    <measurement group_id="O4" value="118.62" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119.63" spread="2.05"/>
                    <measurement group_id="O2" value="122.39" spread="2.01"/>
                    <measurement group_id="O3" value="119.79" spread="1.99"/>
                    <measurement group_id="O4" value="114.72" spread="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>= .04</p_value>
            <method>Linear Mixed Model / Baseline Covariate</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure</title>
        <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.70" spread="1.16"/>
                    <measurement group_id="O2" value="74.85" spread="1.13"/>
                    <measurement group_id="O3" value="72.30" spread="1.09"/>
                    <measurement group_id="O4" value="72.30" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.71" spread="1.21"/>
                    <measurement group_id="O2" value="73.54" spread="1.18"/>
                    <measurement group_id="O3" value="71.23" spread="1.13"/>
                    <measurement group_id="O4" value="71.45" spread="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt; .05</p_value>
            <method>Linear Mixed Model / Baseline Covariate</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.</description>
        <time_frame>12, and 24 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.</description>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.33" spread="1.02"/>
                    <measurement group_id="O2" value="69.16" spread="0.98"/>
                    <measurement group_id="O3" value="66.07" spread="0.95"/>
                    <measurement group_id="O4" value="67.56" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.62" spread="1.22"/>
                    <measurement group_id="O2" value="67.47" spread="1.18"/>
                    <measurement group_id="O3" value="67.11" spread="1.15"/>
                    <measurement group_id="O4" value="70.04" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt; .05</p_value>
            <method>Linear Mixed Model / Baseline Covariate</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Positive Affect Score</title>
        <description>As measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.</description>
        <time_frame>12, and 24 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Affect Score</title>
          <description>As measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.29" spread="0.92"/>
                    <measurement group_id="O2" value="31.18" spread="0.90"/>
                    <measurement group_id="O3" value="32.10" spread="0.92"/>
                    <measurement group_id="O4" value="31.30" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.06" spread="0.84"/>
                    <measurement group_id="O2" value="31.07" spread="0.82"/>
                    <measurement group_id="O3" value="30.83" spread="0.83"/>
                    <measurement group_id="O4" value="31.96" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt; .05</p_value>
            <method>Linear Mixed Model / Baseline Covariate</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Negative Affect Score</title>
        <description>As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.</description>
        <time_frame>12, and 24 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen
Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O2">
            <title>Wild Blueberry Powder - 450mg</title>
            <description>Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine + 2.5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 22.5 mg L-Cysteine @ 2.5 mg L-Glutathione 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O3">
            <title>Wild Blueberry Powder - 900 mg</title>
            <description>Formulation containing containing 450 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen
Wild Blueberry Powder - 900 mg: Formulation containing 450 mg wild blueberry powder = 45 mg L-Cysteine + 5 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
          </group>
          <group group_id="O4">
            <title>Wild Blueberry Extract 100mg</title>
            <description>Formulation containing containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen
Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 389 mg of placebo, once daily, in a 2-hard capsule regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Negative Affect Score</title>
          <description>As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>12 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.04" spread="0.44"/>
                    <measurement group_id="O2" value="13.14" spread="0.42"/>
                    <measurement group_id="O3" value="11.72" spread="0.42"/>
                    <measurement group_id="O4" value="11.53" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.17" spread="0.41"/>
                    <measurement group_id="O2" value="12.18" spread="0.40"/>
                    <measurement group_id="O3" value="12.11" spread="0.40"/>
                    <measurement group_id="O4" value="11.57" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt; .05</p_value>
            <method>Linear Mixed Model / Baseline Covariate</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo: Formulation containing inert artificially colored maltodextrin, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="E2">
          <title>Wild Blueberry Powder - 500mg</title>
          <description>Wild Blueberry Powder - 450mg: Formulation containing 225 mg wild blueberry powder + 45 mg L-Cysteine + 5 mg L-Glutathione + 250 mg placebo powder, once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="E3">
          <title>Wild Blueberry Powder - 1000 mg</title>
          <description>Wild Blueberry Powder - 1000 mg: Formulation containing 900 mg wild blueberry powder + 90 mg L-Cysteine + 10 mg L-Glutathione once daily, in a 2-hard capsule regimen</description>
        </group>
        <group group_id="E4">
          <title>Wild Blueberry Extract 111mg</title>
          <description>Wild Blueberry extract 100mg: Formulation containing 100 mg wild blueberry powder + 10 mg L-Cysteine + 1 mg L-Glutathione + 889 mg of placebo, once daily, in a 2-hard capsule regimen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea / Looser Stool</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Claire Williams</name_or_title>
      <organization>The University of Reading</organization>
      <phone>0118 378 7540</phone>
      <email>claire.williams@reading.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

